FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891512101> ?p ?o ?g. }

• W2891512101 endingPage "2592" @default.
• W2891512101 startingPage "2581" @default.
• W2891512101 abstract "Abstract Renal cell carcinoma (RCC) is the most common malignancy involving the kidneys and a major cause of cancer mortality. The involvement of microRNA (miRNA) expression in the tumorigenesis and progression of RCC has been previously highlighted. Therefore, we conducted this study to investigate whether microRNA‐363 (miR‐363) affects the development of RCC via the Janus tyrosine kinases (JAK2)–signal transducers and activators of transcription (STAT) axis by targeting the growth hormone receptor (GHR), by observing the changes that occurred in the RCC and the normal adjacent tissues of patients with RCC. RCC cells were transfected with a series of miR‐363 mimic, miR‐363 inhibitor, or small interfering RNA against GHR to determine the influence of miR‐363 on the expression of GHR and JAK2–STAT3 axis‐related genes with the use of reverse transcription quantitative polymerase chain reaction and Western blot analysis. The angiogenesis, viability, invasion, and migration of cells were evaluated by means of in vitro angiogenesis, 3‐(4,5)‐dimethylthiahiazo (‐z‐y1)‐3,5‐di‐phenytetrazoliumromide (MTT), wound‐healing, and Transwell assays. The results revealed reduced miR‐363 expression and elevated GHR expression in RCC. It was also found that miR‐363 altered the activation of the JAK2–STAT3 axis through the inhibition of GHR. Cells treated with the miR‐363 inhibitor presented with increased capillary vessels, cell viability, invasion, and migration, whereas it was on the contrary in the RCC cells with overexpressed miR‐363. These results implicated that the overexpression of miR‐363 could specifically bind to GHR to downregulate the expression of GHR, which, in turn, inactivates the JAK2–STAT3 axis, thereby influencing the angiogenesis, cell invasion, and migration abilities in RCC." @default.
• W2891512101 created "2018-09-27" @default.
• W2891512101 creator A5004231602 @default.
• W2891512101 creator A5005835667 @default.
• W2891512101 creator A5019809373 @default.
• W2891512101 creator A5030777217 @default.
• W2891512101 creator A5048254486 @default.
• W2891512101 creator A5055547038 @default.
• W2891512101 creator A5059786172 @default.
• W2891512101 creator A5071773009 @default.
• W2891512101 date "2018-09-19" @default.
• W2891512101 modified "2023-10-18" @default.
• W2891512101 title "<i>Retracted</i>: MicroRNA‐363 inhibits angiogenesis, proliferation, invasion, and migration of renal cell carcinoma via inactivation of the Janus tyrosine kinases 2–signal transducers and activators of transcription 3 axis by suppressing growth hormone receptor gene" @default.
• W2891512101 cites W1665664644 @default.
• W2891512101 cites W1969328011 @default.
• W2891512101 cites W1976043651 @default.
• W2891512101 cites W1977647208 @default.
• W2891512101 cites W2003239693 @default.
• W2891512101 cites W2007103799 @default.
• W2891512101 cites W2008404501 @default.
• W2891512101 cites W2011675507 @default.
• W2891512101 cites W2018773842 @default.
• W2891512101 cites W2020065640 @default.
• W2891512101 cites W2043636495 @default.
• W2891512101 cites W2044967196 @default.
• W2891512101 cites W2055489676 @default.
• W2891512101 cites W2064933387 @default.
• W2891512101 cites W2076761309 @default.
• W2891512101 cites W2093027716 @default.
• W2891512101 cites W2099576888 @default.
• W2891512101 cites W2099908487 @default.
• W2891512101 cites W2111367429 @default.
• W2891512101 cites W2116795476 @default.
• W2891512101 cites W2116949558 @default.
• W2891512101 cites W2130979840 @default.
• W2891512101 cites W2139406867 @default.
• W2891512101 cites W2144154026 @default.
• W2891512101 cites W2149609035 @default.
• W2891512101 cites W2150489662 @default.
• W2891512101 cites W2164704055 @default.
• W2891512101 cites W2166499650 @default.
• W2891512101 cites W2203066110 @default.
• W2891512101 cites W2207792816 @default.
• W2891512101 cites W2413016093 @default.
• W2891512101 cites W2439901648 @default.
• W2891512101 cites W2609591731 @default.
• W2891512101 cites W2625721819 @default.
• W2891512101 doi "https://doi.org/10.1002/jcp.27020" @default.
• W2891512101 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30229899" @default.
• W2891512101 hasPublicationYear "2018" @default.
• W2891512101 type Work @default.
• W2891512101 sameAs 2891512101 @default.
• W2891512101 citedByCount "9" @default.
• W2891512101 countsByYear W28915121012019 @default.
• W2891512101 countsByYear W28915121012020 @default.
• W2891512101 countsByYear W28915121012021 @default.
• W2891512101 crossrefType "journal-article" @default.
• W2891512101 hasAuthorship W2891512101A5004231602 @default.
• W2891512101 hasAuthorship W2891512101A5005835667 @default.
• W2891512101 hasAuthorship W2891512101A5019809373 @default.
• W2891512101 hasAuthorship W2891512101A5030777217 @default.
• W2891512101 hasAuthorship W2891512101A5048254486 @default.
• W2891512101 hasAuthorship W2891512101A5055547038 @default.
• W2891512101 hasAuthorship W2891512101A5059786172 @default.
• W2891512101 hasAuthorship W2891512101A5071773009 @default.
• W2891512101 hasBestOaLocation W28915121011 @default.
• W2891512101 hasConcept C104317684 @default.
• W2891512101 hasConcept C112392421 @default.
• W2891512101 hasConcept C113675107 @default.
• W2891512101 hasConcept C134018914 @default.
• W2891512101 hasConcept C145059251 @default.
• W2891512101 hasConcept C1491633281 @default.
• W2891512101 hasConcept C153911025 @default.
• W2891512101 hasConcept C184235292 @default.
• W2891512101 hasConcept C185592680 @default.
• W2891512101 hasConcept C22615655 @default.
• W2891512101 hasConcept C2778923194 @default.
• W2891512101 hasConcept C2780394083 @default.
• W2891512101 hasConcept C2984496839 @default.
• W2891512101 hasConcept C42362537 @default.
• W2891512101 hasConcept C502942594 @default.
• W2891512101 hasConcept C53227056 @default.
• W2891512101 hasConcept C54009773 @default.
• W2891512101 hasConcept C54355233 @default.
• W2891512101 hasConcept C55493867 @default.
• W2891512101 hasConcept C62112901 @default.
• W2891512101 hasConcept C62478195 @default.
• W2891512101 hasConcept C71315377 @default.
• W2891512101 hasConcept C81885089 @default.
• W2891512101 hasConcept C86803240 @default.
• W2891512101 hasConcept C95444343 @default.
• W2891512101 hasConceptScore W2891512101C104317684 @default.
• W2891512101 hasConceptScore W2891512101C112392421 @default.
• W2891512101 hasConceptScore W2891512101C113675107 @default.
• W2891512101 hasConceptScore W2891512101C134018914 @default.
• W2891512101 hasConceptScore W2891512101C145059251 @default.
• W2891512101 hasConceptScore W2891512101C1491633281 @default.
• W2891512101 hasConceptScore W2891512101C153911025 @default.

• next